AstraZeneca to pay $425 million to settle Nexium, Prilosec litigation in US
(Reuters) – British drugmaker AstraZeneca (NASDAQ:AZN) on Tuesday said it will pay $425 million to settle product liability litigations against…
(Reuters) – British drugmaker AstraZeneca (NASDAQ:AZN) on Tuesday said it will pay $425 million to settle product liability litigations against…
(Reuters) – Meta Platforms is exploring a plan that could make users in the European Union shell out as much…
(Reuters) – X Corp, formerly known as Twitter, was sued in federal court in Florida on Monday by a legal-marketing…
(Reuters) – Oil prices slipped by around 1% in early Asian trade on Tuesday, after falling to a three-week low…
(Reuters) -The Electric Reliability Council of Texas (ERCOT) sought bids from power producers on Monday to increase its operating reserves…
(Reuters) -Blue Origin, the aerospace company founded by billionaire Jeff Bezos, expects to break up a corporate partnership formed years…
Despite experiencing recent downturns, Tesla (NASDAQ:TSLA) is demonstrating promising signs of potential value growth, underpinned by robust financial performance and…
The Indian lender, State Bank of India (SBI) is set to launch the 28th tranche of electoral bonds for sale,…
United Overseas Bank (OTC:UOVEY) (UOB) has become the first Singapore bank to trial Microsoft (NASDAQ:MSFT) 365 Copilot, a Generative Artificial…
(Reuters) – The euro, pound and yen all traded at multi-month lows on Tuesday, with the Japanese currency on the…